Medicine-Pediatrics Endocrinology Fellowship Curriculum

Dual subspecialty training in Med-Peds endocrinology is a four-year pathway. The first two years of fellowship are dedicated to clinical training, with clinical rotations divided between adult and pediatric training sites. The curriculum integrates inpatient and outpatient rotations so that combined Med-Peds trainees have a comprehensive clinical experience in diagnostic evaluation and management of diabetes and endocrine disorders in patients of all ages. Med-Peds fellows will have the same clinical components, including conferences, continuity clinic, and didactic teaching experiences completed by the usual categorical fellow.

The third and fourth years of fellowship are dedicated for scholarly activity. Clinical, translational and basic science research opportunities are available for fellowship research/scholarly activity. Please check out the Endocrinology, Diabetes and Metabolism and Pediatric Diabetes and Endocrinology research websites for more information. A scholarly oversight committee that includes program leadership supervises the trainee’s research/scholarly activity. Med-Peds fellows participate in a core curriculum to support their research/scholarly activity. Combined Med-Peds faculty members are available for mentorship in career development as Med-Peds trainees have diverse career opportunities and are uniquely qualified for careers that span pediatric and adult endocrinology.

Research

The third and fourth years of fellowship are for research/scholarly activity. An array of mentored research endeavors are available, including clinical, translational and basic science. All fellows participate in a core research curriculum.

In addition, each fellow has a Scholarship Oversight Committee. The Scholarship Oversight Committee meets regularly to oversee the fellow's research/scholarly activity, as outlined in the American Board of Pediatrics Training Requirements for Subspecialty Certification.

Training Sites

Fellows rotate through five teaching hospitals, all of which are located within the Texas Medical Center campus.

Texas Children's Hospital/Pavilion for Women, the largest pediatric hospital in the country and a premier academic institution, with a large pediatric endocrine faculty serving a broad array of children and adolescents with endocrine disease. The Pavilion for Women provides state of the art care in obstetrics and gynecology, and is a source of referrals for gestational endocrine disease. Specialized clinical experiences include type 1 and type 2 diabetes, growth and puberty disorders, gender medicine, and thyroid disorders and cancer.

Ben Taub Hospital, the tertiary care referral center for the Harris Health System which provides comprehensive general and specialist care for over 250,000 persons in Harris County, Texas. Specialized clinics include DKA clinic, OB-Endo clinic, HIV lipid disorders clinic, thyroid U/S and FNA clinic, continuity clinic, and urgent discharge clinic.

Baylor St. Luke's Medical Center, the private teaching hospital for adult patients at Baylor College of Medicine, recognized as a top 10 medical center for cardiovascular disease in the United States. Specialized clinics include Pituitary Center, thyroid U/S and FNA clinic, diabetes/metabolic syndrome clinic and general endocrinology clinic.

Michael E. DeBakey Veterans Affairs Medical Center, with 850 active beds serving veterans in a large area of Texas and Louisiana, and a cardiovascular referral hospital for the central portion of the United States. Specialized clinics include comprehensive diabetes program, Insulin pump and continuous glucose monitoring clinic, and general endocrinology clinic.

MD Anderson Cancer Center, which is supported from the State of Texas to care for cancer patients throughout the state, and is recognized nationally and internationally as a top cancer center. Specialized clinics include thyroid cancer, MEN clinic, metabolic bone disease clinic, adolescent endocrine cancer clinic, neuroendocrine tumors, adrenal tumors, and pheochromocytoma.